Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 11
2012 30
2013 23
2014 24
2015 13
2016 21
2017 15
2018 10
2019 7
2020 67
2021 44
2022 13
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Results by year

Filters applied: . Clear all
Page 1
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C. Cao B, et al. N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18. N Engl J Med. 2020. PMID: 32187464 Free PMC article. Clinical Trial.
Psychopharmacology of COVID-19.
Bilbul M, Paparone P, Kim AM, Mutalik S, Ernst CL. Bilbul M, et al. Psychosomatics. 2020 Sep-Oct;61(5):411-427. doi: 10.1016/j.psym.2020.05.006. Epub 2020 May 18. Psychosomatics. 2020. PMID: 32425246 Free PMC article. Review.
Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials.
Izcovich A, Siemieniuk RA, Bartoszko JJ, Ge L, Zeraatkar D, Kum E, Qasim A, Khamis AM, Rochwerg B, Agoritsas T, Chu DK, McLeod SL, Mustafa RA, Vandvik P, Brignardello-Petersen R. Izcovich A, et al. BMJ Open. 2022 Mar 2;12(3):e048502. doi: 10.1136/bmjopen-2020-048502. BMJ Open. 2022. PMID: 35236729 Free PMC article.
SARS-CoV-2 and hepatitis.
Trevenzoli M, Guarnaccia A, Alberici I, Fassan M, Di Meco E, Farinati F, Cattelan AM. Trevenzoli M, et al. J Gastrointestin Liver Dis. 2020 Sep 9;29(3):473-475. doi: 10.15403/jgld-2747. J Gastrointestin Liver Dis. 2020. PMID: 32919428 Free article. No abstract available.
Safety profile of COVID-19 drugs in a real clinical setting.
Chiu MN, Bhardwaj M, Sah SP. Chiu MN, et al. Eur J Clin Pharmacol. 2022 May;78(5):733-753. doi: 10.1007/s00228-021-03270-2. Epub 2022 Jan 28. Eur J Clin Pharmacol. 2022. PMID: 35088108 Free PMC article. Review.
Treating COVID-19 with Chloroquine.
Huang M, Tang T, Pang P, Li M, Ma R, Lu J, Shu J, You Y, Chen B, Liang J, Hong Z, Chen H, Kong L, Qin D, Pei D, Xia J, Jiang S, Shan H. Huang M, et al. J Mol Cell Biol. 2020 May 18;12(4):322-325. doi: 10.1093/jmcb/mjaa014. J Mol Cell Biol. 2020. PMID: 32236562 Free PMC article. Clinical Trial. No abstract available.
240 results